As of 2020, radiation therapy has saved over 3.38 million cancer patients in the US. Radiation therapy treatment planning often involves a time-consuming and labor-intensive process where physicians must manually optimize the prescribed radiation dose.
A Stanford University physician has developed a device to stimulate regeneration of olfactory nerves using minimally invasive electrical neurostimulation.
Scientists at the Stanford Autism Center have invented a questionnaire called the Stanford Social Dimensions Scale (SSDS) for measuring key social processes including social motivation, social communication and social recognition in both the general population and a wide range
This invention involved a new methodology using novel targets, TMS stimulation and a hypnosis protocol to modulate traits and help chronic pain, addiction, and mental disorders.
Stanford researchers have applied large-scale proteomic platforms to identify biomarkers that can be used to diagnose uveal melanoma and subtype eye tumors according to their gene expression profile (GEP) class or PRAME status.
Psoriasis is a chronic skin inflammatory disease that affects 7.5 million people in the US and accounts for $1.2 billion in annual direct medical costs.
Researchers in the Felsher Lab at Stanford University have developed PD-L1 antibody fragment-conjugated nanoparticles to improve upon existing cancer immunotherapies and extend the range of indications to solid tumors.
A team of researchers at Stanford have developed a hydrogel that delivers a scar-reducing focal adhesion kinase inhibitor (FAK-I) to skin grafts and donor sites.
Researchers in Prof. Aaron Hsueh's laboratory have discovered a technique to promote fertility by stimulating the growth of ovarian follicles (functional units that produce oocytes) through disrupting the Hippo signaling pathway.
Dr. Stanley Cohen and colleagues have identified small molecular compounds that may be useful in the treatment of nucleotide repeat diseases. A well-known nucleotide repeat disorder is Huntington's disease.
Researchers in the laboratories of Prof. Stanley Cohen and Prof Tzu-Hao Cheng have discovered that Supt4h is a potential therapeutic target for reducing toxicity and restoring the functionality of deleterious proteins in Huntington's (HD) and other polyQ diseases.
Multiple Sclerosis (MS) is a potentially disabling autoimmune disease whereby autoactivated T and B cells attack and destroy protective myelin sheaths of the central nervous system(CNS).
Stanford researchers have developed a novel technique to control proton beams for radiation therapy to deliver a very high, full dose across a tumor in less than one second.
Researchers at Stanford and the Chan Zuckerberg Biohub have developed a platform for characterizing a population of microbes using spectrally encoded beads.